MRNA Sale Disclosure
Hoge Stephen · SEC Form 4 · Filed Sep 16, 2026
Sale
Calculated transaction value
$5.81M
Hoge Stephen President
MRNA
Moderna
MRNA
Transaction date
Sep 14, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 2 days later
MRNA daily price context
Close on/before transaction
$146.69
Sep 14, 2026
Close before public filing
$143.77
Sep 15, 2026
Return since public filing
+7.01%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 40,294 shares @ $144.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001682852-26-000176
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$13.56M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Exercise | Sep 15, 2026 | $933.48K |
| Moderna, Inc. MRNA | Sale | Sep 15, 2026 | $5.88M |
| Moderna, Inc. MRNA | Exercise | Sep 15, 2026 | $0 |
| Moderna, Inc. MRNA | Exercise | Sep 14, 2026 | $933.49K |
| Moderna, Inc. MRNA Current | Sale | Sep 14, 2026 | $5.81M |
| Moderna, Inc. MRNA | Exercise | Sep 14, 2026 | $0 |